MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30

$2.20−0.09 (-3.93%)

Close on Nov 13, 2026Market cap $140.14MP/E –Yield –

MacroGenics statistics

78 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 8, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $140.14M; $272.32M
Enterprise Value: $91.11M; $146.23M
PS Ratio: 0.90; 3.66
PB Ratio: 5.57; 2.00
P/TBV Ratio: 5.57; 2.22

Enterprise valuationIndustry

EV / Sales: 0.59; 2.57

Share statisticsIndustry

Shares Outstanding: 64M; 58M
Shares Change (YoY): 0.75%; 10.8%
Shares Change (QoQ): 0.36%; 0.50%
Float: 60M; 49M
Shares Held by Insiders: 6.17%; 11.7%
Shares Held by Institutions: 76.4%; 56.4%

Short sellingIndustry

Short Interest: 5M; –
Short Interest Change: -2.19%; -0.80%
Short % of Float: 8.28%; 9.01%
Short % of Shares Outstanding: 7.77%; 6.30%
Days to Cover: 3.86; 5.15

Stock price statisticsIndustry

52-Week High: $5.08; –
52-Week Low: $1.32; –
20-Day Moving Average: $2.56; –
50-Day Moving Average: $3.33; –
200-Day Moving Average: $3.44; –
Average True Range (14): $0.24; –
Price Change (1 Week): -5.58%; -1.15%
Price Change (1 Month): -34.7%; -4.87%
Price Change (3 Months): -45.8%; -21.0%
Price Change (6 Months): -48.2%; -20.6%
Price Change (YTD): 36.6%; -23.6%
Price Change (1 Year): 49.7%; -22.4%
Price Change (3 Years): -68.8%; -29.5%
Price Change (5 Years): -89.0%; -77.9%
Price Change (10 Years): -92.9%; -65.4%
Average Volume (10 Days): 785,442; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 719,101; –
Relative Volume: 1.39; 0.70
Relative Strength Index (14): 31.9; 43.4
Volatility (1 Year): 91.7%; 80.1%
Beta (5 Years): 1.71; 1.07

MarginsIndustry

Operating Margin: -41.5%; -38.7%
Profit Margin: -33.2%; -31.6%
EBITDA Margin: -38.7%; -27.7%
FCF Margin: -26.7%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): -111.8%; -49.9%
Return on Assets (ROA): -17.5%; -40.6%
Return on Capital Employed (ROCE): -30.4%; -37.9%

Financial positionIndustry

Current Ratio: 2.75; 3.30
Quick Ratio: 0.46; 2.39
Interest Coverage: -3.64; -6.35

GrowthIndustry

Revenue Growth (YoY): 67.6%; 6.82%
Revenue Growth (3Y CAGR): -0.54%; 2.25%
Revenue Growth (5Y CAGR): 7.35%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.53; 0.40
Revenue Per Employee: $528.53K; $429.29K
Profits Per Employee: -$175.73K; -$689.41K
Employee Count: 293; 74
WACC: 13.6%; 10.2%

Income statement (TTM)Industry

Revenue: $154.86M; $66.37M
Operating Income: -$64.23M; -$21.37M
Net Income: -$51.49M; -$22.35M
EBITDA: -$59.93M; -$17.21M
EPS (Diluted): -$0.81; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $49.03M; $68.68M
Net Cash (Debt): $49.03M; $17.76M
Net Cash Per Share: $0.77; $0.80
Equity (Book Value): $25.15M; $53.89M
Book Value Per Share: $0.39; $1.50
Tangible Book Value: $25.15M; $27.13M
Working Capital: $187.85M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$39.87M; -$12.38M
Capital Expenditures: -$1.47M; -$1.00M
Free Cash Flow: -$41.34M; -$18.21M
FCF Per Share: -$0.65; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -36.7%; -21.8%
FCF Yield: -29.5%; -9.44%

Taxes and interestIndustry

Interest Expense: $17.64M; $2.90M

Scores and fair valueIndustry

Altman Z-Score: -4.82; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	MGNX	S&P 500	Difference	MGNX per year	S&P 500 per year
1 month	-35.7%	-3.0%	−32.6 pts
3 months	-46.1%	-2.8%	−43.3 pts
Year to date	+36.6%	+11.5%	+25.2 pts
1 year	+37.5%	+13.5%	+24.0 pts
3 years	-65.5%	+77.7%	−143.2 pts	-29.8%	+21.1%
5 years	-89.0%	+72.6%	−161.6 pts	-35.7%	+11.5%
10 years	-92.6%	+308.2%	−400.8 pts	-22.9%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M MGNX shares were sold short on Oct 30, 2026, down 2.2% from the previous report, or 8.28% of the shares available to trade. At recent volumes it would take 3.9 days to buy them back. Over the last 20 sessions, 47.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	4,949,641	-2.2%	1,282,047	3.9
Oct 15, 2026	5,060,376	-28.1%	618,639	8.2
Sep 30, 2026	7,039,348	+0.1%	645,909	10.9
Sep 15, 2026	7,032,428	-1.3%	447,176	15.7
Aug 31, 2026	7,124,937	-1.8%	413,111	17.3
Aug 14, 2026	7,256,491	-1.1%	602,630	12.0
Jul 31, 2026	7,338,558	+29.0%	786,497	9.3
Jul 15, 2026	5,690,928	-14.1%	836,663	6.8
Jun 30, 2026	6,626,533	+38.3%	1,918,736	3.5
Jun 15, 2026	4,790,544	-3.8%	562,075	8.5
May 29, 2026	4,977,397	+2.1%	951,721	5.2
May 15, 2026	4,877,009	+66.4%	1,961,021	2.5